medroxyprogesterone has been researched along with Uterine Neoplasms in 262 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 221 (84.35) | 18.7374 |
1990's | 34 (12.98) | 18.2507 |
2000's | 4 (1.53) | 29.6817 |
2010's | 2 (0.76) | 24.3611 |
2020's | 1 (0.38) | 2.80 |
Authors | Studies |
---|---|
Johnson-Arbor, K; Verstraete, R | 1 |
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS | 1 |
Cuellar-Rodriguez, J; Merideth, M; Purisch, SE; Shanis, D; Stratton, P; Zerbe, C | 1 |
Hsu, SC; Kuo, CH; Lee, JN; Tsai, EM; Yang, CH | 1 |
AZAR, HA; FRICK, HC; SOUTHAM, AL | 1 |
PIACENTINI, G | 1 |
KISTNER, RW | 1 |
MCGARRITY, KA | 1 |
CRAIG, JM; KISTNER, RW; STEINER, GJ | 1 |
ANDERSON, DG | 4 |
Chou, CY; Ho, CL; Hsu, KF; Huang, SC; Lo, CA; Tzeng, CC | 1 |
Houki, N | 1 |
Amato, G; Capuano, F; Carella, C; Figlia, A; Papaleo, C; Zito, GA | 1 |
Bruckner, HW; Cohen, CJ; Deppe, G | 2 |
Barni, S; Gerzeli, G; Novelli, G; Vecchietti, G; Zanoio, L | 1 |
Titova, NP; Titova, VA | 1 |
Kaiser, R; Schulz, KD | 1 |
de la Pena, MM; Deligdisch, L; Deppe, G; Fleming, H; Gurpide, E; Holinka, CF; Namit, C | 1 |
Billiet, G; Bonte, J; De Hertogh, R; Ide, P; Vlaemynck, G | 1 |
Grönroos, M; Kauppila, A; Nieminen, U | 1 |
Boyd, NR; Moazzami, B; Van der Walt, JD | 1 |
Hatcher, RA; Maine, D; Rochat, R; Rosenfield, A; Shelton, J | 1 |
Hocke, M; Röttger, P; Stertmann, WA | 1 |
Fraser, IS | 1 |
Crona, N; Enk, L; Samsioe, G; Silfverstolpe, G; Skryten, A | 1 |
Allegra, JC; Carlson, JA; Day, TG; Wittliff, JL | 1 |
Donadio, C; Fabri, M; Mazzoni, P; Nazzicone, P; Rendina, GM | 1 |
Crona, N; Enk, L; Friberg, LG; Samsioe, G; Silfverstolpe, G | 2 |
Eskola, J; Grönroos, M | 1 |
Kauppila, A | 1 |
Szarvas, Z; Zsolnai, B | 3 |
Bottermann, P; Ermler, R; Glück, H; Henderkott, U; Leis, D | 1 |
Gitsch, E; Salzer, H | 1 |
Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
Minkin, S | 1 |
Ninagawa, T; Ohta, M; Takeda, A; Tomoda, Y | 1 |
Nagasaka, T | 1 |
Cleary, RE; Ehrlich, CE; Young, PC | 1 |
Kauppila, A; Vihko, R | 1 |
McGoldrick, IA | 1 |
Huber, H; Husslein, P; Michalica, W; Wagenbichler, P | 1 |
Bonte, J | 3 |
Barni, S; Gerzeli, G; Novelli, G | 1 |
Mortel, R; Satyaswaroop, PG; Zaino, RJ | 3 |
Eddy, GL; Gaddis, O; Morrow, CP; Nakamura, RM; Nalick, RH; Schlaerth, JB | 1 |
Deligdisch, L; Gurpide, E; Holinka, CF | 1 |
Goldzieher, JW | 1 |
Baulieu, EE; Binart, N; Catelli, MG; George, M; Gravanis, A; Laval, C; Robel, P; Roger-Jallais, L | 1 |
Kahanpää, K; Kärkkäinen, J; Lantta, M; Lehtovirta, P; Wahlström, T; Widholm, O | 1 |
Aslaksen, K; Frankendal, B | 1 |
Backas, NE; Laatikainen, T; Pesonen, K; Stenman, UH; Vesterinen, E | 1 |
Hesselius, I; Johansson, ED | 1 |
Hatcher, RA; Layde, PM; Levenson, AG; Liang, AP; Michelson, MJ; Potts, M; Shelton, JD | 1 |
Grönroos, M; Lehtonen, A | 1 |
Bauer, M; Kubli, F; von Fournier, D; Weber, E | 1 |
Campbell, JJ; Murray, R; Pepperell, RJ; Quinn, MA | 1 |
Barlow, JJ; Blumenson, LE; Lurain, JR; Piver, MS | 1 |
Adlercreutz, H; Härkönen, M | 1 |
Fedele, M; Ferraris, G; Lanza, A; Renzetti, ME | 1 |
Pullè, C; Rigano, A | 1 |
Burnier, F; Cikes, M; Cordey, R; Gloor, E; Hofstetter, J; Knobel, P; Schnyder, P | 1 |
Wittczak-Ploch, E | 1 |
Iversen, OE; Segadal, E; Wilhelmsen, S | 1 |
De Giovanni, C; Galli, MC; Gola, G; Grilli, S; Nanni, P; Nicoletti, G; Orlandi, C; Prodi, G; Rocchetta, R | 1 |
Barni, S; Gerzeli, G; Novelli, GG; Patton, R; Vecchietti, G; Zanoio, L | 1 |
De Grandi, P; Stamm, H | 1 |
Frost, A; Gurpide, E; Satyaswaroop, PG | 1 |
Di Gregorio, A; Fedele, M; Gagna, G; Lanza, A | 1 |
Barlow, JJ; Lele, S; Piver, MS | 1 |
Aspesi, G; Bernardo-Strada, MR; Imparato, E; Pavesi, L; Robustelli Della Cuna, G | 1 |
Imai, S; Motegi, M; Nakajima, T; Sando, Y; Suzuki, T; Takayanagi, N; Ubukata, M; Yoshida, I | 1 |
Barillaro, F; Bazzoffi, R; Capri, O; Critelli, C; Galoppi, P; Perrone, G; Zichella, L | 1 |
Bianchi, S; Fedele, L; Raffaelli, R; Zanconato, G | 1 |
Di Carlo, C; Mastrantonio, P; Noia, R; Palomba, S; Sena, T; Zullo, F | 1 |
Burĕs, J; Malkasian, GD | 1 |
Bolitho, O | 1 |
Gurpide, E; Tseng, L | 1 |
MacLaughlin, DT; Richardson, GS | 2 |
Fukushima, DK; Hellman, L; Kream, J; Levin, J; Yoshida, K; Zumoff, B | 1 |
Cohen, CJ; Deppe, G | 1 |
Jänne, O; Kauppila, A; Kontula, K; Syrjälä, P; Vihko, R | 1 |
Beard, RJ; Campbell, S; McQueen, J; Minardi, J; Whitehead, MI | 1 |
Adlercreutz, H; Laatikainen, T; Nieminen, U | 1 |
De Placido, G; Frollo, G; Leone, F | 1 |
Strickler, RC | 1 |
Creasman, W; DiSaia, P; Morrow, CP; Mortel, R; Prem, K; Sall, S; Thigpen, T | 1 |
Kauppila, AJ; Rautio, A; Sotaniemi, EA; Tuimala, RJ | 1 |
Gammerre, M; Martin, PM; Rolland, PH; Serment, H | 1 |
Gurpide, E; Gusberg, SB; Tseng, L | 1 |
Billiet, G; Bonte, J; Decoster, JM; Ide, P | 1 |
Di Gregorio, A; Fedele, M; Lanza, A | 1 |
Bressler, RS; Fleming, H; Gurpide, E; Satyaswaroop, PG | 1 |
Donadio, C; Rendina, GM | 1 |
Bruckner, HW; Deppe, G | 1 |
Benjamin, I; Block, RE | 1 |
Bonte, J; Decoster, JM; Marcq, A | 1 |
Legrand, M | 1 |
Kohorn, EI | 1 |
Whitfield, CR | 1 |
Kamiyama, M; Sekiya, S; Takamizawa, H | 1 |
de Koos, EB; Dewhurst, CJ; Haines, RM | 1 |
Hustin, J | 1 |
Bullock, JL; Gambrell, RD; Massey, FM | 1 |
Hustin, J; Kremers, P | 1 |
Carrel, S; Mach, JP; Merenda, C; Sordat, B | 1 |
Calì, A; Imparato, E; Marino, L; Pesando, P; Ricciardi, I | 1 |
Diedrich, K; Naether, O | 1 |
Angioli, R; Averette, HE; Donato, D; Nguyen, HN; Penalver, M; Perras, J; Ramos, R; Sevin, BU; Voigt, W | 1 |
Weiss, RM | 1 |
Baird, DT; Lumsden, MA; West, CP | 1 |
Baird, DT; Hillier, H; Lumsden, MA; Sweeting, V; West, CP | 1 |
Ishizaki, T; Itoh, R; Okada, H; Yamamoto, T; Yasuda, J | 1 |
Stone, R | 1 |
Blanchet, P; Friede, J; Lemay, A; Maheux, R; Pratt, X | 1 |
Asmar, P; Paulson, JD; Saffan, DS | 1 |
Averette, HE; Donato, D; Nguyen, HN; Penalver, M; Perras, J; Ramos, R; Sevin, BU | 1 |
Anzai, Y; Ballejo, G; Gong, Y; Gurpide, E; Holinka, CF; Murphy, LC; Murphy, LJ | 1 |
Haney, AF; Lessey, BA; McCarty, KS; Metzger, DA; Soper, JT | 1 |
Brooks, PG; Serden, SP | 1 |
Kato, Y; Kuramoto, H; Morisawa, T | 1 |
Benedetti, MS; Efthymiopoulos, C; Etienne, MC; Frenay, M; Hurteloup, P; Milano, G; Montcuquet, P; Namer, M; René, N; Vo Van, ML | 1 |
Abbondante, G; Aleandri, V; Benagiano, G; Elkind-Hirsch, K; Morini, A; Piccinno, F; Primiero, FM | 1 |
Barbieri, RL | 1 |
Ikeda, T; Kaneko, M; Mori, N | 1 |
Geyer, H; Kleine, W; Maier, T; Pfleiderer, A | 1 |
Fujibayashi, H; Fujimoto, Y; Kitagawa, I; Ohno, Y; Okada, H | 1 |
Benedetto, MT; Bongiorno, M; De Cicco Nardone, F; Dell'Acqua, S; Iacobelli, S; Margariti, PA; Rossiello, F | 1 |
Okada, H; Yamamoto, T | 1 |
King, RJ; Lane, G; Whitehead, MI | 1 |
Fukushima, M; Hirayama, J; Kubo, K; Sekiguchi, M; Takeda, M | 1 |
Breitenecker, G; Czerwenka, K; Kucera, H; Salzer, H; Sevelda, P; Vavra, N | 1 |
Thurzó, L | 1 |
Titova, VA; Voznyĭ, EK | 1 |
Adlercreutz, H; Kärkkäinen, J; Nieminen, U; Stenman, UH; Vesterinen, E; Widholm, O | 1 |
Bellino, R; Colombatto, S; Ferraris, G; Lanza, A; Re, A; Tessarolo, T | 1 |
Lowe, JW; Rand, RJ | 1 |
Mackillop, WJ; Pringle, JF | 1 |
Altaras, MM; Bloch, B; Cloete, K; Goldberg, GL; Wiswedel, K | 1 |
Hando, T; Kurose, T; Motizuki, M; Ohmori, M; Sasagawa, M; Sasaki, T; Tanaka, K; Yamazaki, T; Yasuda, M | 1 |
Honjo, H; Naitoh, K; Okada, H; Urabe, M; Yamamoto, T | 1 |
Fujimoto, J; Fujita, H; Hosoda, S; Okada, H; Tanaka, NG | 1 |
Okamura, S; Okazaki, T; Sugimoto, O; Ueki, M; Yanagawa, Y | 1 |
Fujimori, Y; Hata, T; Hirano, M; Ikeda, S; Okada, T; Tajima, H; Tomioka, Y; Yoshida, T | 1 |
Honjo, H; Kitawaki, J; Okada, H; Urabe, M; Yamamoto, T | 1 |
Feng, YJ; Zhang, XY | 1 |
Atkinson, EN; Freedman, RS; Scott, W; Tatman, JL | 1 |
Fujimoto, J; Fujita, H; Hosoda, S; Okada, H | 1 |
Hosono, T; Kanoh, H; Matsui, Y; Okudaira, Y | 1 |
Berman, ML; DiSaia, PJ; Mannel, RS; Rettenmaier, MA; Stratton, JA | 1 |
Friedman, AJ | 1 |
Manart, FD; Montag, TW | 1 |
Bobrov, IuF; Bokhman, IaV; Fel'dkoren, BI; Tsyrlina, EV; Vishnevskiĭ, AS | 1 |
Ferenczy, A; Gelfand, MM | 1 |
Keen, CE; Philip, G | 1 |
Bush, TL; Ernster, VL; Huggins, GR; Hulka, BS; Kelsey, JL; Schottenfeld, D | 1 |
Balogh, I; Patai, K; Szarvas, Z | 1 |
Ferenczy, A; Gelfand, M | 1 |
Gimes, G; Hidvégi, J; Szarvas, Z; Zsolnai, B | 2 |
Elder, MG; Philipson, KA; White, JO | 1 |
Bonte, J; Ide, P; Janssens, JP | 1 |
Decensi, A; Pavesi, L; Prada, GA; Preti, P; Robustelli della Cuna, G; Zanon, P | 1 |
Gravanis, A; Gurpide, E | 1 |
Amalfitano, TG; Chumas, JC; Mann, WJ; Mazella, J; Stone, ML; Sun, B; Tseng, JK; Tseng, L; Wallach, RC | 1 |
Isotalo, HE; Kauppila, AJ; Kivinen, ST; Vihko, RK | 1 |
Barter, JF; Hatch, KD; Orr, JW; Shingleton, HM | 1 |
Falkay, G; Sas, M; Thurzó, L | 1 |
Griesinger, R; Schindler, AE | 1 |
Atkinson, EN; Freedman, RS; Jones, LA; Kline, RC | 1 |
Cremer, P; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H | 1 |
Erkkola, R; Grenman, S; Grönroos, M; Kangas, L; Mäenpää, J; Paul, R | 1 |
Matsumoto, K; Noguchi, S | 1 |
Fujimoto, J; Fujita, H; Nakata, Y; Okada, H | 1 |
Kitawaki, J | 1 |
Clarke, CL; Mortel, R; Satyaswaroop, PG; Zaino, R | 1 |
Barbieri, RL; Doubilet, PM; Fine, C; Friedman, AJ; Schiff, I | 1 |
Macdonald, RR; Mason, MK; Thorogood, J | 1 |
Kozuka, Y; Murata, K; Sugiyama, Y; Taniguchi, H; Toyoda, N; Uematsu, A; Yamamoto, T | 1 |
Alford, WM; Ehrlich, CE; Stehman, FB; Sutton, GP; Young, PC | 1 |
Carey, TE; England, BG; Grenman, SE; Grönroos, M; Roberts, JA | 1 |
Okada, H | 1 |
Ikegami, H; Inoue, M; Matsumoto, K; Shimizu, I; Tanizawa, O; Terakawa, N | 1 |
Croxtall, JD; Elder, MG; White, JO | 1 |
Audet-Lapointe, P; Ayoub, J; Beaulieu, R; Chemaly, R; Cormier, A; Déry, JP; Drouin, P; Gauthier, P; Hanley, J; Méthot, Y | 1 |
Pronin, VN; Pukhlikov, AV | 1 |
Lahousen, M; Pickel, H | 1 |
Aoki, M; Ishida, M; Nagasawa, H; Sakagami, N | 1 |
Arakawa, O; Hirohashi, T; Obata, N; Ono, M; Sato, Y; Takeuchi, S; Tanaka, K | 1 |
Dallenbach-Hellweg, G | 1 |
Bell, SC; Davidson, AC; MacVicar, J; Waites, GT; Walker, RA; Wood, PL | 1 |
Contreras Ortiz, O; Sananes, CE | 1 |
Egarter, C; Eppel, W; Husslein, P; Salzer, H; Spona, J | 1 |
Barnhill, D; Dames, J; Gallup, D; Heller, P; Hoskins, W; Park, R | 1 |
Goldzieher, JW; Poindexter, AN | 1 |
Grönroos, M; Hietanen, E; Lehtonen, A; Mäntylä, M; Marniemi, J; Niskanen, J; Peltonen, P; Rautio, A | 1 |
Isotalo, H; Kauppila, A; Kivinen, S; Stenbäck, F; Vihko, R | 1 |
Cauchi, M; Fortune, D; Quinn, MA | 1 |
Mortel, R; Satyaswaroop, PG; Whitney, CW | 1 |
Izutsu, T; Kagabu, T; Kurokawa, Y; Nishiya, I; Satoh, K; Yoshizumi, N | 1 |
Matsui, Y; Okudaira, Y; Sawada, M | 1 |
Tanizawa, O; Terakawa, N | 1 |
Hachisuga, M; Hayashi, Y; Tateyama, H | 1 |
Chen, YP; Chuang, SM; Hsieh, CY; Hsu, HC; Huang, SC; Lee, CJ | 1 |
Ohta, T | 1 |
Barengo, R; De Fabiani, E; Giai, M; Sismondi, P; Zola, P | 1 |
Tiltman, AJ | 1 |
Emrich, LJ; Lele, SB; Patsner, B; Piver, MS | 1 |
Nishiya, I; Satoh, K; Yoshizumi, N | 1 |
Daly, PA; O'Briain, DS; O'Brien, AA | 1 |
Labay, GR; Ober, SB | 1 |
Kauppila, A; Vehaskari, A; Ylöstalo, P | 1 |
Ramont, CB | 1 |
Brush, MG; King, RJ; Taylor, RW; Witt, M | 1 |
Ravina, JH | 1 |
Bonte, J; Ide, P | 1 |
Nordqvist, SR | 1 |
Stoll, BA | 1 |
Rosenfield, AG | 1 |
Ferenczy, A; Richart, RM | 1 |
Bross, ID; Lewis, GC; Mortel, R; Slack, NH | 1 |
Halitsky, V; Krumholz, BA; Lobovsky, FY | 1 |
Friedrich, EG; Garancis, JC; Mattingly, RF; Regali, JA; Wilkinson, EJ | 1 |
Sekiya, S; Takamizawa, H; Yano, A | 1 |
Judd, HL; Lucas, WE; Yen, SS | 1 |
Rozier, JC; Underwood, PB | 1 |
Kauppila, A; Sotaniemi, E; Vehaskari, A; Ylöstalo, P | 1 |
Dracopoulou, I; Papadimitriou, G; Razis, D; Zis, J | 1 |
Griffiths, CT; Kistner, RW | 1 |
Gaujoux, J; Laplane, B; Rathelot, P | 1 |
Engeler, V | 1 |
Hester, LL; Horger, EO; Williamson, HO | 1 |
Bonte, J; Drochmans, A; Ide, P | 1 |
Lanza, A | 2 |
Evans, J; Kneale, B | 1 |
Lévy, G; Muller, P | 1 |
Bonte, J; Decoster, JM; Ide, P | 1 |
Ellis, F; Paine, CH; Wright, FW | 1 |
Karjalainen, O; Luukkainen, T | 1 |
Candotti, G; Goisis, M | 1 |
Pasquinucci, C | 1 |
Nilsen, PA | 1 |
Pellillo, D | 1 |
Craft, IL | 1 |
Rutledge, F; Smith, JP; Soffar, SW | 1 |
Piver, MS | 1 |
Bonte, J; Drochmans, A; Ide, P; Lassance, M | 1 |
18 review(s) available for medroxyprogesterone and Uterine Neoplasms
Article | Year |
---|---|
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
Long acting injectable hormonal contraceptives.
Topics: Animals; Breast Neoplasms; Contraceptive Agents; Delayed-Action Preparations; Dogs; Drug Administration Schedule; Female; Fetus; Humans; Infertility, Female; Infusions, Parenteral; Lactation; Macaca mulatta; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Pregnancy; Time Factors; Uterine Neoplasms | 1982 |
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms | 1984 |
Depo provera in perspective.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Contraceptive Agents, Female; Dogs; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Pregnancy; Uterine Cervical Dysplasia; Uterine Neoplasms | 1981 |
[Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
Topics: Adenocarcinoma; Adult; Aged; Female; Humans; Medroxyprogesterone; Middle Aged; Progesterone Congeners; Uterine Neoplasms | 1981 |
[Action of MAP in adenocarcinoma of the endometrium. Clinical results and ultrastructural and histochemical study].
Topics: Adenocarcinoma; Female; Humans; Medroxyprogesterone; Uterine Neoplasms | 1981 |
The management of abnormal uterine bleeding.
Topics: Adult; Anovulation; Biopsy; Clinical Protocols; Female; Humans; Hysteroscopy; Medroxyprogesterone; Menorrhagia; Polyps; Recurrence; Ultrasonography; Uterine Neoplasms; Vagina | 1992 |
Goserelin (Zoladex) in the treatment of fibroids.
Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms | 1992 |
[Therapy of advanced endometrial cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Uterine Neoplasms | 1990 |
[Growth of endometrial cancer and hormone].
Topics: Aged; Antineoplastic Agents; Chemical Phenomena; Chemistry; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone; Thrombosis; Uterine Neoplasms | 1989 |
Progestogen-induced regression in low-grade endometrial stromal sarcoma. Case report and literature review.
Topics: Adult; Drug Therapy, Combination; Endometrium; Female; Humans; Medroxyprogesterone; Sarcoma; Tamoxifen; Uterine Neoplasms | 1989 |
Benefits and risks of menopausal estrogen and/or progestin hormone use.
Topics: Breast Neoplasms; Coronary Disease; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Osteoporosis; Progesterone Congeners; Risk Factors; Uterine Neoplasms | 1988 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
[Conservative organ-preserving measures in precancerous stages of endometrial cancer].
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; Uterine Neoplasms | 1988 |
Hormonal therapy of gynecologic malignancy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Breast Neoplasms; Carcinoma in Situ; Dimethisterone; Drug Therapy, Combination; Estrogens; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone; Neoplasm Metastasis; Norethindrone; Norpregnanes; Progesterone; Prolactin; Recurrence; Uterine Neoplasms; Uterus | 1973 |
Injectable long-acting progestogen contraception: a neglected modality.
Topics: Adult; Amenorrhea; Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Endometriosis; Endometrium; Estrogen Antagonists; Family Planning Services; Female; Fertility; Glucose; Humans; Injections, Intramuscular; Insulin; Medroxyprogesterone; Menstruation Disturbances; Metrorrhagia; Ovulation; Postpartum Period; Pregnancy; Uterine Neoplasms | 1974 |
Endometrial morphologic response to hormonal environment.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma in Situ; Cell Transformation, Neoplastic; Endometrium; Epithelium; Estradiol; Estrogens; Female; Humans; Hyperplasia; Male; Medroxyprogesterone; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mucous Membrane; Ovulation; Progesterone Congeners; Ribosomes; Uterine Neoplasms | 1974 |
Use of progestational agents in the management of metastatic carcinoma of the endometrium.
Topics: Aged; Curettage; Dimethisterone; Endometrium; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Lung Neoplasms; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Progestins; Uterine Neoplasms | 1968 |
27 trial(s) available for medroxyprogesterone and Uterine Neoplasms
Article | Year |
---|---|
Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen; Uterine Neoplasms | 1984 |
Effect of oral medroxyprogesterone acetate on menopausal symptoms in patients with endometrial carcinoma.
Topics: Administration, Oral; Adult; Climacteric; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Medroxyprogesterone; Middle Aged; Random Allocation; Uterine Neoplasms | 1982 |
Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma.
Topics: Adenocarcinoma; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Remission, Spontaneous; Uterine Neoplasms | 1980 |
[Effect of GnRH analogues on bone density in the vertebral column and the femur].
Topics: Adult; Age Factors; Antineoplastic Agents, Hormonal; Bone Density; Female; Femur; Femur Neck; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Lumbar Vertebrae; Medroxyprogesterone; Menstrual Cycle; Premenopause; Progesterone Congeners; Uterine Neoplasms | 1995 |
A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
Topics: Administration, Cutaneous; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Norpregnenes; Progesterone Congeners; Treatment Outcome; Uterine Neoplasms | 2000 |
Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas.
Topics: Administration, Cutaneous; Administration, Oral; Calcium Carbonate; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Postmenopause; Treatment Outcome; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2001 |
Adjuvant progesterone therapy for stage I endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Female; Humans; Hysterectomy; Medroxyprogesterone; Middle Aged; Neoplasm Recurrence, Local; Placebos; Uterine Neoplasms | 1978 |
The effect of medroxyprogesterone acetate on the pituitary-adrenal axis.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Diabetes Mellitus; Female; Humans; Hydrocortisone; Kidney Neoplasms; Male; Medroxyprogesterone; Middle Aged; Pituitary-Adrenal System; Uterine Neoplasms | 1976 |
A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Neoplasm Recurrence, Local; Uterine Neoplasms | 1979 |
[Treatment with progestational agents in the advanced phase of carcinoma of the endometrium. Study of 137 patients treated at the 1st division of obstetrics and gynecology of the San Camillo De Lellis Hospital in Rome].
Topics: Adenocarcinoma; Clinical Trials as Topic; Drug Evaluation; Endometriosis; Female; Hospital Departments; Humans; Medroxyprogesterone; Rome; Time Factors; Uterine Neoplasms | 1975 |
Use of medroxyprogesterone acetate to prevent menopausal symptoms.
Topics: Adult; Breast Neoplasms; Castration; Climacteric; Drug Evaluation; Estrogens; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Medroxyprogesterone; Menopause; Middle Aged; Placebos; Radioimmunoassay; Uterine Neoplasms | 1975 |
Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.
Topics: Adult; Buserelin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Uterine Neoplasms | 1992 |
Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Topics: Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptive Agents, Female; Delayed-Action Preparations; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Thailand; Uterine Neoplasms | 1991 |
Improved bioavailability of a new oral preparation of medroxyprogesterone acetate.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1991 |
Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors; Ultrasonography; Uterine Neoplasms | 1990 |
[Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Tamoxifen; Uterine Neoplasms | 1990 |
[Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Topics: Adenocarcinoma; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1990 |
A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.
Topics: Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Prospective Studies; Random Allocation; Uterine Hemorrhage; Uterine Neoplasms | 1989 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Uterine Neoplasms | 1987 |
Medroxyprogesterone acetate and lipid metabolic changes.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Breast Neoplasms; Cholesterol; Endometriosis; Female; Humans; Lipid Metabolism; Lipids; Lipoproteins; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Triglycerides; Uterine Neoplasms | 1987 |
A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
Topics: Adult; Antineoplastic Agents; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Uterine Neoplasms | 1988 |
A randomized trial of progestogens in the primary treatment of endometrial carcinoma.
Topics: Aged; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Fallopian Tubes; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Random Allocation; Uterine Neoplasms | 1988 |
Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Tamoxifen; Uterine Neoplasms | 1988 |
[The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Random Allocation; Uterine Neoplasms | 1988 |
Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Female; Fluorouracil; Humans; Medroxyprogesterone; Melphalan; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Tamoxifen; Thrombocytopenia; Uterine Neoplasms | 1986 |
Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Clinical Trials as Topic; Endometrium; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placebos; Uterine Neoplasms | 1974 |
218 other study(ies) available for medroxyprogesterone and Uterine Neoplasms
Article | Year |
---|---|
No Bad Blood-Surviving Severe Anemia Without Transfusion.
Topics: Anemia; Bloodless Medical and Surgical Procedures; Female; Ferric Compounds; Hematinics; Humans; Hyperbaric Oxygenation; Infusions, Intravenous; Jehovah's Witnesses; Leiomyoma; Medroxyprogesterone; Middle Aged; Patient-Centered Care; Uterine Hemorrhage; Uterine Neoplasms | 2021 |
Management of uterine bleeding during hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Agents, Hormonal; Contraceptives, Oral, Synthetic; Estrogens; Female; GATA2 Transcription Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Induction Chemotherapy; Leiomyoma; Leuprolide; Medroxyprogesterone; Menorrhagia; Stroke; Uterine Balloon Tamponade; Uterine Neoplasms | 2013 |
Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study.
Topics: Adult; Analysis of Variance; Case-Control Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Neoplasms | 2002 |
Favorable response of metastatic adenocarcinoma of the corpus to massive progrestational therapy: report of a case.
Topics: Adenocarcinoma; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Uterine Neoplasms | 1963 |
[PROGESTOGENS AND ADENOCARCINOMA OF THE ENDOMETRIUM].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Endometrium; Female; Geriatrics; Humans; Medroxyprogesterone; Progesterone; Progestins; Uterine Neoplasms; Vitamin A | 1963 |
STEROID COMPOUNDS WITH PROGESTATIONAL ACTIVITY.
Topics: Contraception; Dysmenorrhea; Endometrial Hyperplasia; Endometriosis; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Menorrhagia; Norethindrone; Norethynodrel; Pregnancy; Progestins; Uterine Neoplasms | 1964 |
HORMONE THERAPY IN GYNAECOLOGY.
Topics: Androgens; Breast Diseases; Drug Therapy; Dysmenorrhea; Endometriosis; Female; Genital Diseases, Female; Gynecology; Humans; Hydroxyprogesterones; Hypertrichosis; Infertility; Infertility, Female; Medroxyprogesterone; Menorrhagia; Mestranol; Metrorrhagia; Nandrolone; Norethindrone; Norethynodrel; Ovulation; Premenstrual Syndrome; Progesterone; Progestins; Testosterone; Uterine Neoplasms | 1964 |
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms | 1963 |
MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE.
Topics: Adenocarcinoma; Disease Management; Female; Geriatrics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Palliative Care; Uterine Neoplasms | 1965 |
Discordant responses to progestin in a patient with uterine low-grade smooth-muscle tumors metastatic to the lung.
Topics: Female; Humans; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Medroxyprogesterone; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 2005 |
[Study on the metabolism of progestins, pregnane compounds, in vivo].
Topics: Autoradiography; Betamethasone; Carbon Isotopes; Chromatography; Dydrogesterone; Female; Humans; Hysterectomy; Medroxyprogesterone; Spectrum Analysis; Tritium; Uterine Neoplasms | 1966 |
ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Uterine Neoplasms | 1984 |
Combination chemotherapy for advanced endometrial adenocarcinoma.
Topics: Adenocarcinoma; Aged; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Melphalan; Middle Aged; Uterine Neoplasms | 1980 |
Chromatin analysis in human endometrial adenocarcinoma before and after treatment with 6-methyl-17-hydroxyprogesterone acetate (MPA).
Topics: Adenocarcinoma; Aged; Aneuploidy; Cell Nucleus; Chromatin; Female; Heterochromatin; Humans; Medroxyprogesterone; Microscopy, Electron; Middle Aged; Uterine Neoplasms | 1981 |
[Clinical and cytological characteristics of endometrial cancer under radiation therapy].
Topics: Aged; Brachytherapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Radioisotope Teletherapy; Radiotherapy Dosage; Uterine Neoplasms | 1981 |
[Current status of drug treatment of endometrial carcinoma].
Topics: Aminoglutethimide; Antineoplastic Agents; Estrogen Antagonists; Female; Humans; Immunotherapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Palliative Care; Patient Care Planning; Uterine Neoplasms | 1983 |
Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
Topics: Adenocarcinoma; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Receptors, Progesterone; Uterine Neoplasms | 1981 |
Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
Topics: Adenocarcinoma; Cell Nucleus; Cytosol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms; Vagina | 1982 |
Clinical outcome in endometrial cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1982 |
Use of progestogens as an adjuvant to surgery in the treatment of stage I adenocarcinoma of the uterine corpus.
Topics: Adenocarcinoma; Adult; Aged; Castration; Female; Gestonorone Caproate; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Postoperative Period; Recurrence; Uterine Neoplasms | 1983 |
The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Topics: Delayed-Action Preparations; Developing Countries; Drug Evaluation; Endometriosis; Family Planning Services; Female; Humans; Injections; Legislation, Drug; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk; United States; Uterine Neoplasms; World Health Organization | 1983 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
[Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Uterine Neoplasms | 1983 |
High-dose depot-medroxyprogesterone acetate (DMPA) - effects on lipid and lipoprotein metabolism.
Topics: Aged; Antineoplastic Agents; Cholesterol; Female; Humans; Lipid Metabolism; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Phospholipids; Triglycerides; Uterine Neoplasms | 1983 |
Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
Topics: Adenocarcinoma; Adult; Aged; Cytosol; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1984 |
Changes in apolipoprotein AI after treatment with high-dose medroxyprogesterone acetate.
Topics: Aged; Apolipoprotein A-I; Apolipoproteins; Delayed-Action Preparations; Depression, Chemical; Female; Humans; Immunoassay; Lipoproteins, HDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Time Factors; Uterine Neoplasms | 1984 |
In vitro functions of lymphocytes during high-dose medroxyprogesterone acetate (MPA) treatment.
Topics: Antibody Formation; B-Lymphocytes; Female; Humans; Leukocyte Count; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone; Medroxyprogesterone Acetate; T-Lymphocytes; Uterine Neoplasms | 1984 |
[Cell surface changes after high-dosage progesterone treatment in endometrial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Microscopy, Electron, Scanning; Microvilli; Middle Aged; Preoperative Care; Progesterone; Surface Properties; Uterine Neoplasms | 1984 |
Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma.
Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Neoplasms, Hormone-Dependent; Organoids; Uterine Neoplasms | 1984 |
The influence of high doses of oral medroxyprogesterone acetate on glucose tolerance, serum insulin levels and adrenal response to ACTH. A study of 17 patients under treatment for endometrial cancer.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1980 |
[The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies].
Topics: Breast Neoplasms; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Progesterone; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1983 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
Depo-Provera: a critical analysis.
Topics: Abnormalities, Drug-Induced; Animals; Breast Feeding; Contraceptive Agents, Female; Dogs; Female; Haplorhini; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; United States; United States Food and Drug Administration; Uterine Neoplasms | 1980 |
[Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1980 |
[Changes of sex steroid hormone receptors in rat uterine cytosol during experimental induction of endometrial carcinoma (author's transl)].
Topics: Animals; Castration; Cytosol; Diethylstilbestrol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Experimental; Rats; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Uterine Neoplasms; Uterus | 1981 |
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1981 |
Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen; Uterine Neoplasms | 1981 |
Radiosensitizing effect of medroxyprogesterone acetate on endometrial cancer cells in vitro.
Topics: Adenocarcinoma; Cell Division; Cells, Cultured; Female; Humans; Medroxyprogesterone; Radiation-Sensitizing Agents; Uterine Neoplasms | 1984 |
The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
Topics: Adenocarcinoma; Administration, Oral; Combined Modality Therapy; Cytosol; Drug Therapy, Combination; Estradiol; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1984 |
Cytochemistry of cell surface sialoglycoconjugates in endometrial adenocarcinoma. Effects of medroxyprogesterone therapy.
Topics: Adenocarcinoma; Aged; Animals; Female; Ferritins; Flow Cytometry; Histocytochemistry; Horseshoe Crabs; Humans; Lectins; Medroxyprogesterone; Membrane Lipids; Membrane Proteins; Microscopy, Electron; Middle Aged; Sialoglycoproteins; Uterine Neoplasms | 1984 |
Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment.
Topics: Adenocarcinoma; Animals; Estradiol; Female; Hysterectomy; Medroxyprogesterone; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1984 |
Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen.
Topics: Chorionic Gonadotropin; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Female; Humans; Hydatidiform Mole; Injections, Intramuscular; Medroxyprogesterone; Pregnancy; Prognosis; Remission, Spontaneous; Risk; Uterine Neoplasms | 1983 |
Histological evaluation of in vitro responses of endometrial adenocarcinoma to progestins and their relation to progesterone receptor levels.
Topics: Adenocarcinoma; Adult; Aged; Cytosol; Female; Humans; Medroxyprogesterone; Middle Aged; Receptors, Progesterone; Uterine Neoplasms | 1984 |
Hormonal contraceptives. Past, present, and future.
Topics: Adolescent; Adult; Breast Diseases; Breast Neoplasms; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Diabetes Complications; Female; Forecasting; Humans; Hypertension; Injections; Lipoproteins; Medroxyprogesterone; Middle Aged; Myocardial Infarction; Ovarian Neoplasms; Risk; Smoking; Thrombophlebitis; Uterine Neoplasms | 1984 |
Female sex steroid receptors in post menopausal endometrial carcinoma. Biochemical responses to antiestrogen and progestin.
Topics: Adenocarcinoma; Animals; Chickens; DNA Polymerase II; Female; Humans; Medroxyprogesterone; Menopause; Oviducts; Progesterone; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1984 |
[Hormone therapy in the follow-up care of gynecologic cancers].
Topics: Female; Genital Neoplasms, Female; Hormones; Humans; Medroxyprogesterone; Postoperative Care; Uterine Neoplasms | 1984 |
[Surface changes in endometrial cancer under the effect of large doses of progestogen (Depo-Provera)].
Topics: Adenocarcinoma; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Medroxyprogesterone; Microscopy, Electron, Scanning; Uterine Neoplasms | 1984 |
Estradiol and progesterone receptors in two cases of endometrial stromal sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Estradiol; Female; Humans; Kinetics; Medroxyprogesterone; Middle Aged; Pregnenediones; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Uterine Neoplasms | 1984 |
Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Castration; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Hysterectomy; Luteinizing Hormone; Medroxyprogesterone; Menopause; Middle Aged; Postoperative Care; Uterine Neoplasms | 1981 |
Medroxyprogesterone acetate (MPA) plasma levels after oral and intramuscular administration in a long-term study.
Topics: Administration, Oral; Female; Humans; Injections, Intramuscular; Long-Term Care; Medroxyprogesterone; Time Factors; Uterine Neoplasms | 1981 |
Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections.
Topics: Adolescent; Adult; Black People; Breast Neoplasms; Child; Female; Follow-Up Studies; Humans; Injections; Medroxyprogesterone; Middle Aged; Ovarian Neoplasms; Risk; Uterine Neoplasms | 1983 |
Effect of high dose progestin on serum lipids.
Topics: Aged; Anticholesteremic Agents; Cholesterol; Female; Humans; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1983 |
[High-dosage gestagen long-term therapy in corpus carcinoma; influence on survival time (author's transl)].
Topics: Aged; Female; Humans; Life Expectancy; Medrogestone; Medroxyprogesterone; Middle Aged; Pregnadienes; Prognosis; Uterine Neoplasms | 1981 |
Tamoxifen and aminoglutethimide in the management of patients with advanced endometrial carcinoma not responsive to medroxyprogesterone.
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Drug Resistance; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Tamoxifen; Uterine Neoplasms | 1981 |
Enzymatic assay of medroxyprogesterone acetate in plasma.
Topics: Alcohol Oxidoreductases; Cortisone Reductase; Female; Humans; Malate Dehydrogenase; Male; Medroxyprogesterone; Radioimmunoassay; Sex Factors; Uterine Neoplasms | 1980 |
Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy.
Topics: Abdominal Neoplasms; Adult; Endometriosis; Female; Humans; Hysterectomy; Medroxyprogesterone; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Time Factors; Tomography, X-Ray Computed; Uterine Neoplasms | 1982 |
[Results of treatment of advanced cases of endometrial cancer with high doses of medroxyprogesterone].
Topics: Adenocarcinoma; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Uterine Neoplasms | 1982 |
[Tamoxifen. A new antiestrogen effective against uterine neoplasms].
Topics: Adenocarcinoma; Aged; Estrogen Antagonists; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Neoplasm Recurrence, Local; Tamoxifen; Uterine Neoplasms | 1982 |
Multiple steroid hormone receptors in normal and abnormal human endometrium.
Topics: Endometrium; Female; Humans; Medroxyprogesterone; Middle Aged; Receptors, Steroid; Uterine Neoplasms | 1980 |
[Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
Topics: Adenocarcinoma; Aged; DNA, Neoplasm; Female; Humans; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1981 |
[Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone].
Topics: Adenocarcinoma; Adult; Female; Humans; Medroxyprogesterone; Metrorrhagia; Uterine Neoplasms | 1981 |
Metabolism and effects of progesterone in the human endometrial adenocarcinoma cell line HEC-1.
Topics: Adenocarcinoma; Cell Division; Cell Line; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Female; Humans; Medroxyprogesterone; Progesterone; Uterine Neoplasms | 1980 |
[Medroxyprogesterone acetate treatment of a case of hyperadrenalism with adenocarcinoma of the endometrium].
Topics: Adenocarcinoma; Adrenocortical Hyperfunction; Female; Humans; Medroxyprogesterone; Middle Aged; Postoperative Care; Uterine Neoplasms | 1980 |
Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.
Topics: Adenocarcinoma; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Melphalan; Neoplasm Metastasis; Neoplasm Recurrence, Local; Uterine Neoplasms | 1980 |
[Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1980 |
[A case of so-called benign metastasizing leiomyoma responsive to progesterone].
Topics: Female; Humans; Leiomyoma; Leiomyosarcoma; Lung Neoplasms; Medroxyprogesterone; Middle Aged; Remission Induction; Uterine Neoplasms | 1993 |
Primary malignant tumours of the body of the uterus.
Topics: Adenocarcinoma; Adult; Aged; Diabetes Complications; Female; Humans; Hypertension; Hysterectomy; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Obesity; Radon; Sarcoma; Uterine Neoplasms; Vaginal Neoplasms | 1975 |
Induction of human endometrial estradiol dehydrogenase by progestins.
Topics: Adenocarcinoma; Adenoma; Culture Techniques; Dactinomycin; Endometrium; Enzyme Induction; Estradiol Dehydrogenases; Estrogens, Conjugated (USP); Female; Humans; Hydroxysteroid Dehydrogenases; Medroxyprogesterone; Menstruation; Norgestrel; Progesterone; Puromycin; Uterine Neoplasms | 1975 |
Progesterone binding by normal and abnormal human endometrium.
Topics: Adenocarcinoma; Binding, Competitive; Carcinoma, Squamous Cell; Cytosol; Endometrium; Female; Humans; Hydrocortisone; Hyperplasia; Kinetics; Medroxyprogesterone; Muscle Proteins; Progesterone; Protein Binding; Receptors, Cell Surface; Uterine Neoplasms | 1976 |
Endometrial carcinoma and oral contraceptive agents.
Topics: Adenocarcinoma; Adult; Contraceptives, Oral; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Dimethisterone; Drug Combinations; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Hyperplasia; Medroxyprogesterone; Middle Aged; Norgestrel; Time Factors; Uterine Neoplasms | 1977 |
Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration.
Topics: Adenocarcinoma; Adult; Cytosol; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Middle Aged; Progesterone; Progestins; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1979 |
The effects of cyclical oestrogen therapy and sequential oestrogen/progestogen therapy on the endometrium of postmenopausal women.
Topics: Endometrium; Estrogens; Female; Follow-Up Studies; Humans; Hyperplasia; Medroxyprogesterone; Menopause; Norethindrone; Uterine Hemorrhage; Uterine Neoplasms; Vacuum Curettage | 1977 |
Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.
Topics: Adenocarcinoma; Administration, Oral; Aged; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1979 |
[MAP in the treatment of adenocarcinoma of the endometrium].
Topics: Adenocarcinoma; Drug Evaluation; Female; Humans; Medroxyprogesterone; Uterine Neoplasms | 1979 |
Dysfunctional uterine bleeding: diagnosis and treatment.
Topics: Adolescent; Adult; Anovulation; Contraceptives, Oral; Dilatation and Curettage; Endometriosis; Estrogens; Female; Humans; Hysterectomy; Medroxyprogesterone; Menstruation Disturbances; Progesterone; Uterine Hemorrhage; Uterine Neoplasms | 1979 |
Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
Topics: Adult; Aged; Aging; Antipyrine; Female; Half-Life; Humans; Liver; Liver Function Tests; Medroxyprogesterone; Middle Aged; Time Factors; Uterine Neoplasms | 1979 |
[OEstradiol and progesterone steroid hormone receptors in cancer of the endometrium. The significance of the progesterone receptor (author's transl)].
Topics: Endometrium; Estradiol; Female; Humans; Medroxyprogesterone; Norprogesterones; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1979 |
[Beneficial effects of contraceptive doses and large doses of medroxyprogesterone in the prevention and treatment of uterine hyperplasia].
Topics: Adenocarcinoma; Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Uterine Cervical Neoplasms; Uterine Neoplasms | 1978 |
Estrogen metabolism in normal and neoplastic endometrium.
Topics: Adenocarcinoma; Aged; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogens; Female; Humans; Medroxyprogesterone; Menstruation; Progesterone; Receptors, Estrogen; Uterine Neoplasms | 1977 |
Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate.
Topics: Adenocarcinoma; Evaluation Studies as Topic; Female; Humans; Medroxyprogesterone; Neoplasm Recurrence, Local; Prognosis; Radium; Silicone Elastomers; Uterine Neoplasms | 1978 |
[Progestin treatment in a case of adrenal cortex hyperfunction with cancer of the endometrium].
Topics: Adenocarcinoma; Adrenocortical Hyperfunction; Female; Humans; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1978 |
Human endometrial cancer cell cultures for hormonal studies.
Topics: Adenocarcinoma; Animals; Cell Line; Cell Nucleus; Cricetinae; Cytosol; Estradiol; Estradiol Dehydrogenases; Female; Humans; Medroxyprogesterone; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Progesterone; Receptors, Estrogen; Transplantation, Heterologous; Uterine Neoplasms | 1978 |
Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
Topics: Adenocarcinoma; Aged; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Uterine Neoplasms | 1977 |
Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis.
Topics: Adolescent; Adult; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estrogens; Female; Humans; Medroxyprogesterone; Progesterone; Turner Syndrome; Uterine Neoplasms | 1977 |
Medroxyprogesterone acetate release from silastic devices as replacement for local irradiation by radium tubes in preoperative intrauterine packing for endometrial adenocarcinoma: a preliminary study.
Topics: Adenocarcinoma; Aged; Drug Evaluation; Female; Humans; Intrauterine Devices, Medicated; Medroxyprogesterone; Middle Aged; Preoperative Care; Radium; Silicone Elastomers; Uterine Neoplasms | 1977 |
Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
Topics: Adenocarcinoma; Aged; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Melphalan; Middle Aged; Uterine Neoplasms | 1977 |
[Apparent cure with a progestagen of endometrial cancer with pulmonary metastases].
Topics: Adenocarcinoma; Aged; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Neoplasm Metastasis; Uterine Neoplasms | 1976 |
Gestagens and endometrial carcinoma.
Topics: Female; Humans; Hydroxyprogesterones; Medrogestone; Medroxyprogesterone; Megestrol; Progesterone; Progestins; Uterine Neoplasms | 1976 |
Treatment and prognosis of endometrial cancer.
Topics: Female; Humans; Hydroxyprogesterones; Hysterectomy, Vaginal; Medroxyprogesterone; Postoperative Care; Preoperative Care; Progestins; Prognosis; Uterine Neoplasms | 1976 |
In vivo and in vitro tests of inhibitory effect of progesterone on cell-mediated immunity in rats bearing a syngeneic uterine adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cell Division; Clone Cells; Female; Immunity, Cellular; Immunologic Techniques; Lung Neoplasms; Medroxyprogesterone; Neoplasm Metastasis; Neoplasms, Experimental; Progesterone; Rats; Spleen; Uterine Neoplasms | 1975 |
Replacement hormone therapy in gonadal dysgenesis.
Topics: Adolescent; Adult; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogens; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Megestrol; Norethindrone; Polyps; Progestins; Turner Syndrome; Uterine Neoplasms | 1975 |
Effect of protein hormones and steroids on tissue cultures of endometrial carcinoma.
Topics: Autoradiography; Cell Survival; Culture Techniques; DNA; Endometrium; Estradiol; Estriol; Ethylestrenol; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Pregnenolone; Progesterone; Progesterone Congeners; Thymidine; Uterine Neoplasms | 1975 |
Steroid 17alpha-hydroxylase activity in normal and cancerous endometria.
Topics: Endometrium; Female; Humans; Medroxyprogesterone; Menstruation; Steroid Hydroxylases; Time Factors; Uterine Neoplasms | 1975 |
Human endometrial carcinomas serially transplanted in nude mice and established in continuous cell lines.
Topics: Adenocarcinoma; Animals; Cell Line; Cell Transformation, Neoplastic; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Stimulation, Chemical; Transplantation, Heterologous; Uterine Neoplasms | 1975 |
[MAP in the therapy of adenocarcionoma of the endometrium. Immediate clinical results and general endocrine effects].
Topics: Adenocarcinoma; Endocrine Glands; Female; Humans; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1975 |
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
Topics: Adult; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Receptors, LHRH; Uterine Neoplasms | 1992 |
Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometry.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Agents; Biological Assay; Female; Flow Cytometry; Humans; Luminescent Measurements; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1992 |
[Effect of high-dose medroxyprogesterone acetate on coagulative and fibrinolytic factors in patients with gynecological cancers].
Topics: Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Protein C; Uterine Neoplasms | 1992 |
Depo-Provera. Controversial contraceptive wins approval from FDA panel.
Topics: Adult; Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Legislation, Drug; Medroxyprogesterone; Medroxyprogesterone Acetate; Osteoporosis; United States; United States Food and Drug Administration; Uterine Neoplasms | 1992 |
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
Topics: Adult; Antineoplastic Agents; Bone Density; Buserelin; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Pilot Projects; Triglycerides; Uterine Neoplasms | 1991 |
Mild and moderate endometriosis. Comparison of treatment modalities for infertile couples.
Topics: Adult; Antineoplastic Agents; Cautery; Danazol; Endometriosis; Female; Follow-Up Studies; Humans; Infertility, Female; Laparoscopy; Laparotomy; Laser Therapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Retrospective Studies; Uterine Neoplasms | 1991 |
The effects of Provera on chemotherapy of uterine cancer cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Topics: Antineoplastic Agents; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; RNA, Messenger; RNA, Neoplasm; Transforming Growth Factor alpha; Transforming Growth Factor beta; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
Topics: Adult; Antineoplastic Agents; Endometriosis; Female; Humans; Hysterectomy; Immunohistochemistry; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1991 |
Treatment of abnormal uterine bleeding with the gynecologic resectoscope.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Agents; Catheterization; Danazol; Electrocoagulation; Endometrium; Female; Humans; Hysteroscopes; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Uterine Neoplasms; Uterus | 1991 |
[Growth regulation of sex steroid hormone in endometrial carcinoma transplanted into nude mice].
Topics: Adenocarcinoma; Animals; Cell Division; Endometriosis; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Uterine Neoplasms | 1990 |
[Effect of medroxyprogesterone acetate on cerebral blood flow].
Topics: Antineoplastic Agents; Cerebrovascular Circulation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uterine Neoplasms | 1990 |
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Multivariate Analysis; Neoplasm Invasiveness; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Survival Analysis; Uterine Neoplasms | 1990 |
Medroxyprogesterone acetate binding sites in human endometrium and endometrial cancer.
Topics: Binding Sites; Centrifugation, Density Gradient; Endometrium; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Progesterone; Uterine Neoplasms | 1990 |
Hormone receptors and enzymatic activities in human endometrial adenocarcinoma.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Cell Nucleus; Creatine Kinase; Cytosol; Endometrium; Female; Humans; Interferon Type I; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1990 |
The histochemistry of oestradiol-17 beta dehydrogenase in normal endometrium and endometrial carcinoma: a test to predict the sensitivity of endometrial carcinoma to progestogens: a preliminary report.
Topics: 17-Hydroxysteroid Dehydrogenases; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Uterine Neoplasms | 1990 |
[A case of marked effectiveness using medroxyprogesterone acetate (MPA) in lung metastases of cancer of the uterine body].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Remission Induction; Uterine Neoplasms | 1990 |
[Progestins in combined treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progestins; Uterine Neoplasms | 1990 |
Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer.
Topics: Aged; Antineoplastic Agents; Female; Gas Chromatography-Mass Spectrometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Radioimmunoassay; Time Factors; Uterine Neoplasms | 1990 |
Biochemical aspects of the hormonal therapy of endometrial adenocarcinoma.
Topics: Adenocarcinoma; Female; Glucose-6-Phosphate; Glucosephosphates; Glycolysis; Humans; Medroxyprogesterone; Ornithine Decarboxylase; Polyamines; Uterine Neoplasms | 1990 |
Low-grade endometrial stromal sarcoma treated with a progestogen.
Topics: Administration, Oral; Adult; Endometrium; Female; Humans; Medroxyprogesterone; Sarcoma; Tomography, X-Ray Computed; Uterine Neoplasms | 1990 |
Designing a schedule of progestin administration in the control of endometrial carcinoma growth in the nude mouse model.
Topics: Animals; Blotting, Western; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Male; Medroxyprogesterone; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Progestins; Receptors, Progesterone; Uterine Neoplasms | 1990 |
Stage III endometrial carcinoma. A review of 90 cases.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Radiotherapy Dosage; Retrospective Studies; Time Factors; Uterine Neoplasms | 1985 |
Medroxyprogesterone acetate in non-metastatic gestational trophoblastic disease.
Topics: Adolescent; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Peptide Fragments; Pregnancy; Prospective Studies; Recurrence; Trophoblastic Neoplasms; Uterine Neoplasms | 1987 |
[Diagnosis and treatment of endometrial hyperplasia].
Topics: ABO Blood-Group System; Adenocarcinoma; DNA Polymerase II; Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Oncogenes; Protein Biosynthesis; Receptors, Estrogen; Uterine Neoplasms | 1989 |
Estrone sulfatase activity in normal and neoplastic endometrial tissues of human uterus.
Topics: Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Progesterone; Sulfatases; Uterine Neoplasms | 1989 |
Effect of medroxyprogesterone acetate on secondary spreading of endometrial cancer.
Topics: Angiogenesis Inducing Agents; Animals; Antineoplastic Agents; Basement Membrane; Cell Adhesion; Cell Line; Cells, Cultured; Female; Fibroblast Growth Factors; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Tumor Cells, Cultured; Uterine Neoplasms | 1989 |
[Effect of medroxyprogesterone acetate on side effects of CAP therapy in gynecological malignant tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Leukocyte Count; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Platelet Count; Uterine Neoplasms | 1989 |
[Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Reoperation; Uterine Neoplasms | 1989 |
Estrogen biosynthesis in human uterine adenomyosis.
Topics: Adult; Aromatase; Cells, Cultured; Danazol; Endometriosis; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Uterine Neoplasms | 1989 |
[Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Progesterone; Uterine Neoplasms | 1989 |
Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Thrombophlebitis; Uterine Neoplasms | 1989 |
Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
Topics: Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Norethindrone; Receptors, Progesterone; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uterine Neoplasms | 1989 |
Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.
Topics: Actuarial Analysis; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Subrenal Capsule Assay; Uterine Neoplasms | 1989 |
Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
Topics: Bone and Bones; Climacteric; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Ultrasonography; Uterine Neoplasms; Uterus | 1989 |
Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Estrogens, Conjugated (USP); Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Pelvic Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Renal Veins; Sarcoma; Uterine Neoplasms; Vena Cava, Inferior | 1989 |
[Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents; Cytoplasm; Drug Evaluation; Female; Homeostasis; Humans; Hydroxyprogesterones; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Preoperative Care; Receptors, Cell Surface; Reproduction; Uterine Neoplasms; Vaginal Smears | 1989 |
Cytochemical examinations of Ca, cytochrome oxidase and succinate dehydrogenase enzymes in endometrium carcinomatous tissue after high dose progestogen treatment.
Topics: Antineoplastic Agents; Calcium; Electron Transport Complex IV; Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Mitochondria; Succinate Dehydrogenase; Uterine Neoplasms | 1988 |
The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Middle Aged; Prospective Studies; Recurrence; Uterine Neoplasms | 1989 |
High-dose depot-medroxyprogesterone acetate--effects on the fatty acid composition of serum lecithin and cholesterol ester.
Topics: 8,11,14-Eicosatrienoic Acid; Aged; Arachidonic Acid; Arachidonic Acids; Cholesterol Esters; Fatty Acids; Female; Humans; Linoleic Acid; Linoleic Acids; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palmitic Acids; Phosphatidylcholines; Stearic Acids; Uterine Neoplasms | 1985 |
[Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
Topics: Aged; Carcinoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrium; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron, Scanning; Preoperative Care; Uterine Neoplasms | 1985 |
The effects of medroxyprogesterone acetate on enzyme activities in human endometrial carcinoma.
Topics: Creatine Kinase; Cytosol; Enzyme Activation; Female; Glucosephosphate Dehydrogenase; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1985 |
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms | 1986 |
Effects of estradiol on deoxyribonucleic acid polymerase alpha activity in the Ishikawa human endometrial adenocarcinoma cell line.
Topics: Adenocarcinoma; Cell Line; DNA Polymerase II; Enzyme Activation; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen; Uterine Neoplasms | 1986 |
Endocrine aspects of human uterine sarcoma: a preliminary study.
Topics: Adult; Aged; Aminoglutethimide; Animals; Aromatase; Aromatase Inhibitors; Cells, Cultured; Estradiol; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Middle Aged; Nandrolone; Neoplasm Transplantation; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Uterine Neoplasms | 1986 |
Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Topics: Aged; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Myometrium; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1986 |
The status of receptors in the management of endometrial cancer.
Topics: Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Progesterone; Prognosis; Receptors, Progesterone; Uterine Neoplasms | 1986 |
Isolated abdominal wound recurrence of an endometrial adenocarcinoma confined to a polyp.
Topics: Abdominal Neoplasms; Adenocarcinoma; Combined Modality Therapy; Electrons; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Seeding; Ovariectomy; Polyps; Time Factors; Uterine Neoplasms | 1986 |
[Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Topics: Adenocarcinoma; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1986 |
[Therapy with gestagens in hyperplastic changes of the endometrium].
Topics: Adenocarcinoma; Adenoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1986 |
Steroid receptors and response of endometrial cancer to hormones in vitro.
Topics: Adenocarcinoma; Adenosine Triphosphate; Drug Combinations; Drug Screening Assays, Antitumor; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Receptors, Steroid; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1987 |
[Hormone therapy--recent advances].
Topics: Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms | 1987 |
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms | 1987 |
[Studies on estradiol dehydrogenase activity in the human uterine endometrium].
Topics: 17-Hydroxysteroid Dehydrogenases; Dose-Response Relationship, Drug; Endometrium; Estradiol Dehydrogenases; Female; Hormones; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Uterine Neoplasms | 1987 |
Nude mouse system in the study of tumor biology, treatment strategies and progesterone receptor physiology in human endometrial carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Differentiation; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Transplantation, Heterologous; Uterine Neoplasms | 1987 |
Continuous, high-dose progestogen treatment of endometrial cancer.
Topics: Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron, Scanning; Uterine Neoplasms | 1987 |
[A case of stromal endometriosis (endolymphatic stromal myosis) in the effective treatment with progestogen].
Topics: Adult; Endometriosis; Female; Humans; Hysterectomy; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Pneumonectomy; Uterine Neoplasms | 1988 |
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Injections, Intramuscular; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1988 |
In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line; Depression, Chemical; Drug Evaluation; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Postoperative Care; Receptors, Steroid; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
[Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Topics: Estrenes; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Neoplasms, Hormone-Dependent; Norethindrone; Norgestrel; Progesterone Congeners; Receptors, Progesterone; Tumor Stem Cell Assay; Uterine Neoplasms | 1988 |
Inhibitory effects of danazol and medroxyprogesterone acetate on [3H]thymidine incorporation in human endometrial cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Cell Division; Danazol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Receptors, Progesterone; Thymidine; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Progestin regulation of protein synthesis in endometrial cancer.
Topics: Cells, Cultured; Creatine Kinase; Electrophoresis, Polyacrylamide Gel; Female; Humans; Isoelectric Focusing; Isoelectric Point; Medroxyprogesterone; Medroxyprogesterone Acetate; Molecular Weight; Organ Culture Techniques; Progesterone; Progestins; Protein Biosynthesis; Tubulin; Uterine Neoplasms | 1988 |
[Characteristics of the surgical stage in the combined treatment of poorly differentiated cancer of the corpus uteri].
Topics: Adenocarcinoma; Brachytherapy; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymph Node Excision; Medroxyprogesterone; Medroxyprogesterone Acetate; Mesonephroma; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Time Factors; Uterine Neoplasms | 1988 |
[Adjuvant gestagen therapy in stage I endometrial cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Uterine Neoplasms | 1988 |
Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.
Topics: Animals; Cell Transformation, Neoplastic; Endometriosis; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Organ Size; Precancerous Conditions; Uterine Neoplasms | 1988 |
[Experimental study of the treatment of uterine leiomyosarcoma in the mouse with progestogen].
Topics: Animals; Female; Leiomyosarcoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Receptors, Estrogen; Uterine Neoplasms | 1988 |
Immunohistological localization of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG) in endometrial adenocarcinoma and effect of medroxyprogesterone acetate.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Endometrium; Female; Glycodelin; Glycoproteins; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pregnancy Proteins; Uterine Neoplasms | 1988 |
Hormonal receptors in endometrial neoplasias.
Topics: Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Receptors, Estradiol; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1988 |
Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Dilatation and Curettage; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Hyperplasia; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Radiotherapy; Radiotherapy Dosage; Risk; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms | 1985 |
Medical aspects of contraception.
Topics: Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Medroxyprogesterone; Risk; Uterine Neoplasms | 1987 |
Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.
Topics: Adipose Tissue; Adult; Aged; Cholesterol; Cholesterol, HDL; Female; Humans; Lipids; Lipoprotein Lipase; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Triglycerides; Uterine Neoplasms | 1985 |
Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adult; Aged; Cell Nucleus; Cytosol; Danazol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Middle Aged; Pregnadienes; Receptors, Estrogen; Receptors, Progesterone; Temperature; Time Factors; Uterine Neoplasms | 1985 |
Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
Topics: Adenocarcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Uterine Neoplasms | 1985 |
Plasminogen activator activity in human endometrial carcinoma.
Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Plasminogen Activators; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1985 |
[Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
Topics: Adenocarcinoma; Adult; Aged; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; RNA, Neoplasm; Software; Uterine Neoplasms | 1985 |
[Effects of long-term high doses of sex steroid hormones on human endometrial adenocarcinoma transplanted into nude mice].
Topics: Adenocarcinoma, Papillary; Animals; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Uterine Neoplasms | 1985 |
[Growth inhibition by progestins in human endometrial cancer cells with progesterone receptors].
Topics: Cell Division; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Neoplasms, Hormone-Dependent; Progesterone Congeners; Promegestone; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
[Successful treatment of advanced endometrial carcinoma with pleural effusion due to cancer by cisplatin, doxorubicin, and medroxyprogesterone acetate].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometriosis; Female; Humans; Medroxyprogesterone; Middle Aged; Pleural Effusion; Uterine Neoplasms | 1987 |
A case of endometrial stromatosis with pulmonary metastasis: remission following surgical and hormonal treatment.
Topics: Adult; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Remission Induction; Uterine Neoplasms | 1987 |
[Simultaneous cytofluorometric studies on DNA and protein in endometrial adenocarcinoma--with reference to gestagen treatment].
Topics: Adenocarcinoma; Adult; Aged; DNA, Neoplasm; Female; Humans; Medroxyprogesterone; Microscopy, Fluorescence; Middle Aged; Neoplasm Proteins; Uterine Neoplasms | 1986 |
[Hormonotherapy of carcinoma of the endometrium].
Topics: Female; Hormones; Humans; Medroxyprogesterone; Neoplasms, Hormone-Dependent; Progestins; Tamoxifen; Uterine Neoplasms | 1986 |
The effect of progestins on the mitotic activity of uterine fibromyomas.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Leiomyoma; Levonorgestrel; Medroxyprogesterone; Middle Aged; Mitosis; Norethindrone; Norgestrel; Uterine Neoplasms; Uterus | 1985 |
Hormonal therapy of human endometrial adenocarcinoma in a nude mouse model.
Topics: Adenocarcinoma; Animals; Castration; Disease Models, Animal; Estradiol; Female; Humans; Medroxyprogesterone; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Progestins; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms | 1985 |
[The effects of progestogens on a human endometrial cancer cell line Ishikawa and a human breast cancer cell line MCF-7].
Topics: Breast Neoplasms; Cell Cycle; Cell Line; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Progesterone; RNA, Neoplasm; Uterine Neoplasms | 1985 |
Aggressive endometrial stromal sarcoma responding to medroxyprogesterone following failure of tamoxifen and combination chemotherapy. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Sarcoma; Tamoxifen; Uterine Neoplasms | 1985 |
The possible mechanisms of action of progestins on endometrial adenocarcinoma.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenocarcinoma; Aged; Biopsy; Blood Cell Count; Blood Protein Electrophoresis; Endometrium; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Immunity; Luteinizing Hormone; Lymphocytes; Medroxyprogesterone; Middle Aged; Palliative Care; Pregnanediol; Remission, Spontaneous; Time Factors; Uterine Neoplasms | 1972 |
The histopathology of the endometrium: selected topics.
Topics: Adenocarcinoma; Biopsy; Chlormadinone Acetate; Contraceptives, Oral; Endometrial Hyperplasia; Endometritis; Endometrium; Estradiol; Estrogens; Female; Histocytochemistry; Humans; Intrauterine Devices; Medroxyprogesterone; Menstruation; Mestranol; Microscopy, Electron; Norethynodrel; Norgestrel; Ovulation; Time Factors; Uterine Neoplasms | 1972 |
Effects of high-dose medroxyprogesterone given for endometrial carcinoma on serum proteins.
Topics: Administration, Oral; Adult; Aged; Blood Proteins; Depression, Chemical; Female; Glycoproteins; Haptoglobins; Humans; Immunodiffusion; Injections, Intramuscular; Medroxyprogesterone; Middle Aged; Serum Albumin; Serum Globulins; Stimulation, Chemical; Time Factors; Uterine Neoplasms | 1974 |
Cyclic hormonetherapy. A report on 305 cases.
Topics: Adult; Aged; Breast Neoplasms; Coronary Disease; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis; Uterine Neoplasms; Vaginal Smears | 1966 |
The uptake of oestrogen by endometrial carcinoma.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Carcinosarcoma; Cell Nucleus; DNA; DNA, Neoplasm; Endometrium; Estradiol; Estrogens; Female; Humans; Medroxyprogesterone; Neoplasms, Germ Cell and Embryonal; Progestins; Uterine Cervical Neoplasms; Uterine Neoplasms; Vaginal Neoplasms | 1971 |
[Gestagens and uterine neoplasms].
Topics: Age Factors; Cells, Cultured; Drug Synergism; Female; Humans; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Experimental; Progesterone; Prognosis; Receptors, Cell Surface; Uterine Neoplasms | 1973 |
Proceedings: Vaginal cytologic evaluation as a predictive test on hormone dependency and responsiveness to progestogens of endometrial adenocarcinoma.
Topics: Adenocarcinoma; Endometrium; Female; Humans; Medroxyprogesterone; Progestins; Prognosis; Uterine Neoplasms; Vaginal Smears | 1974 |
In vitro effects of progestins on DNA synthesis in metastatic endometrial carcinoma.
Topics: Adolescent; Adult; Aged; Cells, Cultured; DNA, Neoplasm; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Hydroxyprogesterones; Mathematics; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Progesterone; Uterine Neoplasms | 1974 |
Medroxyprogesterone in the management of primary and recurrent or metastatic uterine adenocarcinoma.
Topics: Adenocarcinoma; Female; Humans; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Uterine Neoplasms | 1972 |
Endolymphatic stromal myosis with pulmonary metastases. Remission with progestin therapy: report of a case.
Topics: Adult; Female; Humans; Hydroxyprogesterones; Hysterectomy; Lung Neoplasms; Medroxyprogesterone; Neoplasm Metastasis; Progestins; Radiography; Sarcoma; Uterine Cervical Neoplasms; Uterine Neoplasms | 1973 |
Turner's syndrome with endometrial adenocarcinoma and stilbestrol therapy.
Topics: Adenocarcinoma; Adult; Biopsy; Diethylstilbestrol; Endometrium; Female; Humans; Hydroxyprogesterones; Hysterectomy; Karyotyping; Medroxyprogesterone; Turner Syndrome; Uterine Neoplasms | 1973 |
Enhancement of tumor growth and metastases by medroxyprogesterone acetate in transplanted uterine adenocarcinoma cells of the rat.
Topics: Adenocarcinoma; Animals; Cells, Cultured; Female; Lung Neoplasms; Male; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Transplantation; Rats; Transplantation, Homologous; Uterine Neoplasms | 1974 |
Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Aged; Androstenedione; Castration; Curettage; Estrogens; Fallopian Tubes; Female; Humans; Hysterectomy; Medroxyprogesterone; Menopause; Metabolic Clearance Rate; Middle Aged; Ovary; Radioimmunoassay; Testosterone; Uterine Neoplasms | 1974 |
Use of progestational agents in endometrial adenocarcinoma.
Topics: Adenocarcinoma; Administration, Oral; Endometrium; Female; Humans; Injections, Intramuscular; Medrogestone; Medroxyprogesterone; Megestrol; Neoplasm Metastasis; Neoplasm Recurrence, Local; Progestins; Uterine Neoplasms | 1974 |
Effects of high-dose medroxyprogesterone treatment given for endometrial carcinoma on carbohydrate metabolism and liver function.
Topics: Administration, Oral; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Depression, Chemical; Female; Glucose Tolerance Test; Humans; Injections, Intramuscular; Insulin; Liver; Liver Function Tests; Medroxyprogesterone; Middle Aged; Stimulation, Chemical; Time Factors; Uterine Neoplasms | 1974 |
Preoperative hormonal treatment in endometrial carcinoma.
Topics: Adult; Female; Humans; Medroxyprogesterone; Middle Aged; Preoperative Care; Uterine Neoplasms | 1974 |
[Bone metastasis revealing a cancer of the endometrium].
Topics: Adenocarcinoma; Bone Neoplasms; Female; Humans; Ischium; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prognosis; Pubic Bone; Time Factors; Uterine Neoplasms | 1972 |
[Treatment of metastasizing carcinoma of the uterus with gestagens].
Topics: Adenocarcinoma; Aged; Carcinoma; Female; Humans; Hydroxyprogesterones; Lung Neoplasms; Lynestrenol; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnanes; Progestins; Prognosis; Uterine Neoplasms | 1971 |
The treatment of uterine adenocarcinoma with medroxyprogesterone acetate.
Topics: Adenocarcinoma; Aged; Female; Humans; Male; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1966 |
Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
Topics: Adenocarcinoma; Administration, Oral; Estrogens; Female; Histocytochemistry; Humans; Injections, Intramuscular; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Time Factors; Uterine Neoplasms; Vagina; Vaginal Neoplasms; Vaginal Smears | 1970 |
[Study of hepatic function and carbohydrate metabolism during therapy with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate in adenocarcinoma of the uterine body. II. Influence on carbohydrate metabolism].
Topics: Adenocarcinoma; Adult; Blood Glucose; Carbohydrate Metabolism; Diabetes Complications; Female; Glucose Tolerance Test; Humans; Medroxyprogesterone; Uterine Neoplasms | 1969 |
[Study of hepatic function and carbohydrate metabolism during therapy with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate in adenocarcinoma of the uterine body. I. Influence on the electrophoretic protein pattern, and serum transaminases and alkaline
Topics: Adenocarcinoma; Adult; Alkaline Phosphatase; Blood Protein Electrophoresis; Blood Proteins; Carbohydrate Metabolism; Female; Humans; Hypoproteinemia; Liver; Medroxyprogesterone; Transaminases; Uterine Neoplasms | 1969 |
Progestogen therapy for advanced carcinoma of the endometrium.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Endometrium; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Norethindrone; Progesterone; Time Factors; Uterine Neoplasms | 1969 |
Evaluation of the mechanism of action of a progestin on endometrial andenocarcinoma.
Topics: Adenocarcinoma; Animals; Dogs; Endometrium; Estrogen Antagonists; Female; Humans; Immunosuppressive Agents; Medroxyprogesterone; Mononuclear Phagocyte System; Uterine Neoplasms | 1969 |
[Hormones and genital cancer in women].
Topics: Adult; Endometrium; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Ovarian Neoplasms; Progesterone; Testosterone; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 1969 |
Radiosensitization of endometrial adenocarcinoma by means of medroxyprogesterone.
Topics: Adenocarcinoma; Adult; Female; Humans; Medroxyprogesterone; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radium; Uterine Neoplasms | 1970 |
The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Uterine Neoplasms | 1970 |
Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
Topics: Acetates; Carcinoma; Endometrium; Female; Humans; Medroxyprogesterone; Neoplasm Recurrence, Local; Pregnanes; Progestins; Radium; Uterine Neoplasms | 1970 |
[Gynecological indications of a new progestational agent with prolonged action].
Topics: Abortion, Threatened; Adenocarcinoma; Adolescent; Adult; Breast Neoplasms; Delayed-Action Preparations; Endometriosis; Female; Genital Diseases, Female; Genital Neoplasms, Female; Humans; Leiomyoma; Medroxyprogesterone; Menstruation Disturbances; Middle Aged; Pregnancy; Tuberculosis, Female Genital; Uterine Cervical Neoplasms; Uterine Neoplasms | 1970 |
[Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
Topics: Adenocarcinoma; Adult; Aged; Blood Glucose; Carbohydrate Metabolism; Female; Glucose Tolerance Test; Humans; Medroxyprogesterone; Middle Aged; Uterine Neoplasms | 1970 |
Hormonal treatment of recurrent endometrial carcinoma. Report of a case.
Topics: Adenocarcinoma; Endometrium; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms | 1968 |
Proliferative stromatosis of the uterus with pulmonary metastases. Remission following treatment with a longacting synthetic progestin: a case report.
Topics: Adult; Endometriosis; Female; Humans; Hysterectomy; Lung Neoplasms; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Neoplasms; Uterine Neoplasms | 1968 |
Local use of progestogen in cancer.
Topics: Adenocarcinoma; Adult; Female; Humans; Injections; Medroxyprogesterone; Neoplasm Metastasis; Pleural Neoplasms; Uterine Neoplasms | 1969 |
Progestins in the treatment of endometrial carcinoma.
Topics: Adenocarcinoma; Endometrium; Female; Humans; Medroxyprogesterone; Neoplasm Metastasis; Prognosis; Uterine Neoplasms | 1965 |
Progestins in the treatment of patients with endometrial adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Humans; Medroxyprogesterone; Middle Aged; Progestins; Uterine Neoplasms | 1966 |
Distant metastasis of adenoacanthoma of the endometrium.
Topics: Adenocarcinoma; Aged; Endometrium; Female; Follow-Up Studies; Humans; Lung Neoplasms; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Uterine Neoplasms | 1966 |
[Chemotherapeutic treatment with progestational hormones in preparation for curietherapy and surgery of adenocarcinoma of the endometrium].
Topics: Adenocarcinoma; Endometrium; Female; Humans; Medroxyprogesterone; Preoperative Care; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radium; Uterine Neoplasms | 1966 |